Los-Arcos I - Search Results

1

Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis.

Los-Arcos I, Pigrau C, Rodríguez-Pardo D, Fernández-Hidalgo N, Andreu A, Larrosa N, Almirante B. Los-Arcos I, et al. Antimicrob Agents Chemother. 2015 Dec 14;60(3):1854-8. doi: 10.1128/AAC.02611-15. Antimicrob Agents Chemother. 2015. PMID: 26666924 Free PMC article.

2

Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis.

Aguilar-Company J, Los-Arcos I, Pigrau C, Rodríguez-Pardo D, Larrosa MN, Rodríguez-Garrido V, Sihuay-Diburga D, Almirante B. Aguilar-Company J, et al. Antimicrob Agents Chemother. 2016 Jun 20;60(7):4398-400. doi: 10.1128/AAC.00447-16. Print 2016 Jul. Antimicrob Agents Chemother. 2016. PMID: 27161640 Free PMC article.

3

Reply to "Activity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origin".

Aguilar-Company J, Los-Arcos I, Pigrau C, Almirante B. Aguilar-Company J, et al. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e02448-16. doi: 10.1128/AAC.02448-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 28119318 Free PMC article. No abstract available.

4

Ceftazidime-Avibactam plus Aztreonam for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria.

Sempere A, Viñado B, Los-Arcos I, Campany D, Larrosa N, Fernández-Hidalgo N, Rodríguez-Pardo D, González-López JJ, Nuvials X, Almirante B, Escolà-Vergé L. Sempere A, et al. Among authors: los arcos i. Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0075122. doi: 10.1128/aac.00751-22. Epub 2022 Sep 14. Antimicrob Agents Chemother. 2022. PMID: 36102635 Free PMC article.

5

Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections.

Escolà-Vergé L, Pigrau C, Los-Arcos I, Arévalo Á, Viñado B, Campany D, Larrosa N, Nuvials X, Ferrer R, Len O, Almirante B. Escolà-Vergé L, et al. Infection. 2018 Aug;46(4):461-468. doi: 10.1007/s15010-018-1133-5. Epub 2018 Mar 28. Infection. 2018. PMID: 29594953

6

Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended-spectrum beta-lactamase: Can they be successfully treated with cephalosporins?

Escolà-Vergé L, Larrosa N, Los-Arcos I, Viñado B, González-López JJ, Pigrau C, Almirante B, Len O. Escolà-Vergé L, et al. J Glob Antimicrob Resist. 2019 Dec;19:28-31. doi: 10.1016/j.jgar.2019.02.016. Epub 2019 Feb 27. J Glob Antimicrob Resist. 2019. PMID: 30825700

7

New antibiotics for the treatment of infections by multidrug-resistant microorganisms.

Escolà-Vergé L, Los-Arcos I, Almirante B. Escolà-Vergé L, et al. Med Clin (Barc). 2020 May 8;154(9):351-357. doi: 10.1016/j.medcli.2019.11.002. Epub 2020 Jan 8. Med Clin (Barc). 2020. PMID: 31926653 Review. English, Spanish.

8

An overview of ceftolozane sulfate + tazobactam for treating hospital acquired pneumonia.

Los-Arcos I, Burgos J, Falcó V, Almirante B. Los-Arcos I, et al. Expert Opin Pharmacother. 2020 Jun;21(9):1005-1013. doi: 10.1080/14656566.2020.1739269. Epub 2020 Mar 26. Expert Opin Pharmacother. 2020. PMID: 32212866 Review.

9

Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).

de Cueto M, Aliaga L, Alós JI, Canut A, Los-Arcos I, Martínez JA, Mensa J, Pintado V, Rodriguez-Pardo D, Yuste JR, Pigrau C. de Cueto M, et al. Enferm Infecc Microbiol Clin. 2017 May;35(5):314-320. doi: 10.1016/j.eimc.2016.11.005. Epub 2016 Dec 23. Enferm Infecc Microbiol Clin. 2017. PMID: 28017477 English, Spanish.

10

Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study).

Castón JJ, Cano A, Pérez-Camacho I, Aguado JM, Carratalá J, Ramasco F, Soriano A, Pintado V, Castelo-Corral L, Sousa A, Fariñas MC, Muñoz P, Abril López De Medrano V, Sanz-Peláez Ó, Los-Arcos I, Gracia-Ahufinger I, Pérez-Nadales E, Vidal E, Doblas A, Natera C, Martínez-Martínez L, Torre-Cisneros J. Castón JJ, et al. J Antimicrob Chemother. 2022 Apr 27;77(5):1452-1460. doi: 10.1093/jac/dkac049. J Antimicrob Chemother. 2022. PMID: 35187577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page